Nanophotonics Biosensors for Ultrasensitive Diagnostics — Laura Lechuga | Duke FIP

2022 Fitzpatrick Institute Symposium at Duke University: COVID-19 pandemics has evidenced the urgent need for reliable and portable diagnostic tools, able to deliver rapid testing and screening of the population while providing sensitivity and specificity levels comparable to laboratory techniques. Biosensor technology is the most suitable one to tackle the challenging goal of offering fast and user-friendly diagnostics tests than can be employed at the point-of-need. In particular, photonic biosensors can provide sensitive, reliable and selective analysis, while reducing the time-to-result, decreasing and/or eliminating sample transport, and using low sample volume. And, more importantly, photonic biosensor technology can provide quantification, for example, of the SARS-CoV-2 viral load.